UB Paderborn / Katalog / Suche / in CDI

Characterization of Novel Selective H1-Antihistamines for Clinical Evaluation in the Treatment of Insomnia

Journal of medicinal chemistry, 2009-09, Vol.52 (17), p.5307-5310

2009

Volltextzugriff (PDF)

Kinetic operational models of agonism for G-protein-coupled receptors

Journal of theoretical biology, 2018-06, Vol.446, p.168-204

2018

Volltextzugriff (PDF)

Efficacy of Vesicular Monoamine Transporter 2 Inhibition and Synergy with Antipsychotics in Animal Models of Schizophrenia

The Journal of pharmacology and experimental therapeutics, 2022-05, Vol.381 (2), p.79

2022

Volltextzugriff (PDF)

Lead optimization of 2-(piperidin-3-yl)-1H-benzimidazoles: Identification of 2-morpholin- and 2-thiomorpholin-2-yl-1H-benzimidazoles as selective and CNS penetrating H1-antihistamines for insomnia

Bioorganic & medicinal chemistry letters, 2012-01, Vol.22 (1), p.421-426

2012

Volltextzugriff (PDF)

Brain-penetrating 2-aminobenzimidazole H1-antihistamines for the treatment of insomnia

Bioorganic & medicinal chemistry letters, 2009-08, Vol.19 (15), p.4380-4384

2009

Volltextzugriff (PDF)

Drugability of Extracellular Targets: Discovery of Small Molecule Drugs Targeting Allosteric, Functional, and Subunit-Selective Sites on GPCRs and Ion Channels

Neuropsychopharmacology (New York, N.Y.), 2009-01, Vol.34 (1), p.106-125

2009

Volltextzugriff (PDF)

The discovery and structure-activity relationships of 2-(piperidin-3-yl)-1H-benzimidazoles as selective, CNS penetrating H1-antihistamines for insomnia

Bioorganic & medicinal chemistry letters, 2010-05, Vol.20 (9), p.2916-2919

2010

Volltextzugriff (PDF)

Identification of a novel selective H1-antihistamine with optimized pharmacokinetic properties for clinical evaluation in the treatment of insomnia

Bioorganic & medicinal chemistry letters, 2010-10, Vol.20 (19), p.5874-5878

2010

Volltextzugriff (PDF)

Novel benzothiophene H1-antihistamines for the treatment of insomnia

Bioorganic & medicinal chemistry letters, 2010-04, Vol.20 (7), p.2316-2320

2010

Volltextzugriff (PDF)

Influence of pKₐ on the biotransformation of indene H₁-antihistamines by CYP2D6

Bioorganic & medicinal chemistry letters, 2011-02, Vol.21 (3), p.947-951

2011

Volltextzugriff (PDF)

Characterization of Novel Selective H 1 -Antihistamines for Clinical Evaluation in the Treatment of Insomnia

Journal of medicinal chemistry, 2009-09, Vol.52 (17), p.5307-5310

2009

Volltextzugriff (PDF)

Identification of a novel selective H 1-antihistamine with optimized pharmacokinetic properties for clinical evaluation in the treatment of insomnia

Bioorganic & medicinal chemistry letters, 2010-10, Vol.20 (19), p.5874-5878

2010

Volltextzugriff (PDF)

Selectivity profiling of novel indene H 1-antihistamines for the treatment of insomnia

Bioorganic & medicinal chemistry letters, 2010-04, Vol.20 (8), p.2629-2633

2010

Volltextzugriff (PDF)

Novel benzothiophene H 1-antihistamines for the treatment of insomnia

Bioorganic & medicinal chemistry letters, 2010-04, Vol.20 (7), p.2316-2320

2010

Volltextzugriff (PDF)

Selectivity profiling of novel indene H1-antihistamines for the treatment of insomnia

Bioorganic & medicinal chemistry letters, 2010-04, Vol.20 (8), p.2629-2633

2010

Volltextzugriff (PDF)

Brain-penetrating 2-aminobenzimidazole H sub(1)-antihistamines for the treatment of insomnia

Bioorganic & medicinal chemistry letters, 2009-08, Vol.19 (15), p.4380-4384

2009

Volltextzugriff (PDF)

Drugability of Extracellular Targets : Discovery of Small Molecule Drugs Targeting Allosteric, Functional, and Subunit-Selective Sites on GPCRs and Ion Channels: CNS Drug Discovery and Development: Challenges and Opportunities

Neuropsychopharmacology (New York, N.Y.), 2009, Vol.34 (1), p.106-125

2009

Volltextzugriff (PDF)

Influence of pK sub(a) on the biotransformation of indene H sub(1)-antihistamines by CYP2D6

Bioorganic & medicinal chemistry letters, 2011-02, Vol.21 (3), p.947-951

2011

Volltextzugriff (PDF)

Non-peptide CRF-Receptor Antagonists: Allosterism, Kinetics and Translation to Efficacy in Human Disease

Current molecular pharmacology, 2017, Vol.10 (4), p.282

2017

Volltextzugriff (PDF)

Brain-penetrating 2-aminobenzimidazole H(1)-antihistamines for the treatment of insomnia

Bioorganic & medicinal chemistry letters, 2009-08, Vol.19 (15), p.4380-4384

2009

Volltextzugriff (PDF)

The discovery and structure-activity relationships of 2-(piperidin-3-yl)-1H-benzimidazoles as selective, CNS penetrating H sub(1)-antihistamines for insomnia

Bioorganic & medicinal chemistry letters, 2010-05, Vol.20 (9), p.2916-2919

2010

Volltextzugriff (PDF)

Selectivity profiling of novel indene H sub(1)-antihistamines for the treatment of insomnia

Bioorganic & medicinal chemistry letters, 2010-04, Vol.20 (8), p.2629-2633

2010

Volltextzugriff (PDF)

Novel benzothiophene H sub(1)-antihistamines for the treatment of insomnia

Bioorganic & medicinal chemistry letters, 2010-04, Vol.20 (7), p.2316-2320

2010

Volltextzugriff (PDF)

Selectivity profiling of novel indene H(1)-antihistamines for the treatment of insomnia

Bioorganic & medicinal chemistry letters, 2010-04, Vol.20 (8), p.2629-2633

2010

Volltextzugriff (PDF)

Allosteric regulation of rat and human dopamine receptor subtypes: evidence for two binding states for [3H]spiperone

Biochemical Society transactions, 1996-02, Vol.24 (1), p.53S

1996

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Characterization of Novel Selective H1-Antihistamines for Clinical Evaluation in the Treatment of Insomnia

Kinetic operational models of agonism for G-protein-coupled receptors

Efficacy of Vesicular Monoamine Transporter 2 Inhibition and Synergy with Antipsychotics in Animal Models of Schizophrenia

Lead optimization of 2-(piperidin-3-yl)-1H-benzimidazoles: Identification of 2-morpholin- and 2-thiomorpholin-2-yl-1H-benzimidazoles as selective and CNS penetrating H1-antihistamines for insomnia

Brain-penetrating 2-aminobenzimidazole H1-antihistamines for the treatment of insomnia

Drugability of Extracellular Targets: Discovery of Small Molecule Drugs Targeting Allosteric, Functional, and Subunit-Selective Sites on GPCRs and Ion Channels

The discovery and structure-activity relationships of 2-(piperidin-3-yl)-1H-benzimidazoles as selective, CNS penetrating H1-antihistamines for insomnia

Identification of a novel selective H1-antihistamine with optimized pharmacokinetic properties for clinical evaluation in the treatment of insomnia

Novel benzothiophene H1-antihistamines for the treatment of insomnia

Influence of pKₐ on the biotransformation of indene H₁-antihistamines by CYP2D6

Characterization of Novel Selective H 1 -Antihistamines for Clinical Evaluation in the Treatment of Insomnia

Identification of a novel selective H 1-antihistamine with optimized pharmacokinetic properties for clinical evaluation in the treatment of insomnia

Selectivity profiling of novel indene H 1-antihistamines for the treatment of insomnia

Novel benzothiophene H 1-antihistamines for the treatment of insomnia

Selectivity profiling of novel indene H1-antihistamines for the treatment of insomnia

Brain-penetrating 2-aminobenzimidazole H sub(1)-antihistamines for the treatment of insomnia

Drugability of Extracellular Targets : Discovery of Small Molecule Drugs Targeting Allosteric, Functional, and Subunit-Selective Sites on GPCRs and Ion Channels: CNS Drug Discovery and Development: Challenges and Opportunities

Influence of pK sub(a) on the biotransformation of indene H sub(1)-antihistamines by CYP2D6

Non-peptide CRF-Receptor Antagonists: Allosterism, Kinetics and Translation to Efficacy in Human Disease

Brain-penetrating 2-aminobenzimidazole H(1)-antihistamines for the treatment of insomnia

The discovery and structure-activity relationships of 2-(piperidin-3-yl)-1H-benzimidazoles as selective, CNS penetrating H sub(1)-antihistamines for insomnia

Selectivity profiling of novel indene H sub(1)-antihistamines for the treatment of insomnia

Novel benzothiophene H sub(1)-antihistamines for the treatment of insomnia

Selectivity profiling of novel indene H(1)-antihistamines for the treatment of insomnia

Allosteric regulation of rat and human dopamine receptor subtypes: evidence for two binding states for [3H]spiperone

Suchergebnisse filtern